A randomized, placebo-controlled, double-blind, prospective trial to evaluate the effect of vildagliptin in new-onset diabetes mellitus after kidney transplantation

Overview of attention for article published in Trials, October 2010

Altmetric Badge

Mentioned by

policy: 1 policy source

Readers on

mendeley: 58 Mendeley

Summary Policy documents

So far, Altmetric has seen 1 policy document that references this research output.

Newer Drugs for Type 2 Diabetes: An Emerging Adjunctive Therapy to Insulin for Type 1 Diabetes?

Cited by Canadian Agency for Drugs and Technologies in Health on 19 Jan 2018

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.